These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34925435)

  • 1. Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing.
    Gao F; Tian L; Shi H; Zheng P; Wang J; Dong F; Hu K; Ke X
    Front Genet; 2021; 12():677650. PubMed ID: 34925435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
    Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
    Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
    Michot JM; Quivoron C; Sarkozy C; Danu A; Lazarovici J; Saleh K; El-Dakdouki Y; Goldschmidt V; Bigenwald C; Dragani M; Bahleda R; Baldini C; Arfi-Rouche J; Martin-Romano P; Tselikas L; Gazzah A; Hollebecque A; Lacroix L; Ghez D; Vergé V; Marzac C; Cotteret S; Rahali W; Soria JC; Massard C; Bernard OA; Dartigues P; Camara-Clayette V; Ribrag V
    Am J Hematol; 2023 Apr; 98(4):645-657. PubMed ID: 36606708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.
    Morin RD; Assouline S; Alcaide M; Mohajeri A; Johnston RL; Chong L; Grewal J; Yu S; Fornika D; Bushell K; Nielsen TH; Petrogiannis-Haliotis T; Crump M; Tosikyan A; Grande BM; MacDonald D; Rousseau C; Bayat M; Sesques P; Froment R; Albuquerque M; Monczak Y; Oros KK; Greenwood C; Riazalhosseini Y; Arseneault M; Camlioglu E; Constantin A; Pan-Hammarstrom Q; Peng R; Mann KK; Johnson NA
    Clin Cancer Res; 2016 May; 22(9):2290-300. PubMed ID: 26647218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup.
    Jiang S; Qin Y; Jiang H; Liu B; Shi J; Meng F; Liu P; Yang J; Yang S; He X; Zhou S; Gui L; Liu H; Lin J; Han-Zhang H; Shi Y
    Int J Cancer; 2020 Nov; 147(9):2611-2620. PubMed ID: 32399964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
    Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
    BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.
    Juskevicius D; Jucker D; Klingbiel D; Mamot C; Dirnhofer S; Tzankov A
    J Hematol Oncol; 2017 Mar; 10(1):70. PubMed ID: 28302137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma.
    Li P; Chai J; Chen Z; Liu Y; Wei J; Liu Y; Zhao D; Ma J; Wang K; Li X; Shao Y; Gong L; Zhang W; Guo S; Yan Q; Li M; Fan L; Wang Z
    Front Oncol; 2021; 11():622648. PubMed ID: 33747936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
    Lee B; Lee H; Cho J; Yoon SE; Kim SJ; Park WY; Kim WS; Ko YH
    Front Oncol; 2021; 11():628807. PubMed ID: 33777778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma.
    Xian RR; Xie Y; Haley LM; Yonescu R; Pallavajjala A; Pittaluga S; Jaffe ES; Duffield AS; McCall CM; Gheith SMF; Gocke CD
    Blood Cancer J; 2020 Jun; 10(6):69. PubMed ID: 32555149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and prognosis of rrDLBCL with TP53 mutations and a high-risk subgroup represented by the co-mutations of DDX3X-TP53.
    Gao F; Hu K; Zheng P; Shi H; Ke X
    Cancer Med; 2023 May; 12(9):10267-10279. PubMed ID: 36971051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma.
    Mareschal S; Dubois S; Viailly PJ; Bertrand P; Bohers E; Maingonnat C; Jaïs JP; Tesson B; Ruminy P; Peyrouze P; Copie-Bergman C; Fest T; Jo Molina T; Haioun C; Salles G; Tilly H; Lecroq T; Leroy K; Jardin F
    Genes Chromosomes Cancer; 2016 Mar; 55(3):251-67. PubMed ID: 26608593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.
    Chapuy B; Cheng H; Watahiki A; Ducar MD; Tan Y; Chen L; Roemer MG; Ouyang J; Christie AL; Zhang L; Gusenleitner D; Abo RP; Farinha P; von Bonin F; Thorner AR; Sun HH; Gascoyne RD; Pinkus GS; van Hummelen P; Wulf GG; Aster JC; Weinstock DM; Monti S; Rodig SJ; Wang Y; Shipp MA
    Blood; 2016 May; 127(18):2203-13. PubMed ID: 26773040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of primary
    Greenawalt DM; Liang WS; Saif S; Johnson J; Todorov P; Dulak A; Enriquez D; Halperin R; Ahmed A; Saveliev V; Carpten J; Craig D; Barrett JC; Dougherty B; Zinda M; Fawell S; Dry JR; Byth K
    Oncotarget; 2017 Nov; 8(59):99237-99244. PubMed ID: 29245897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.
    Mareschal S; Pham-Ledard A; Viailly PJ; Dubois S; Bertrand P; Maingonnat C; Fontanilles M; Bohers E; Ruminy P; Tournier I; Courville P; Lenormand B; Duval AB; Andrieu E; Verneuil L; Vergier B; Tilly H; Joly P; Frebourg T; Beylot-Barry M; Merlio JP; Jardin F
    J Invest Dermatol; 2017 Sep; 137(9):1984-1994. PubMed ID: 28479318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.
    Lohr JG; Stojanov P; Lawrence MS; Auclair D; Chapuy B; Sougnez C; Cruz-Gordillo P; Knoechel B; Asmann YW; Slager SL; Novak AJ; Dogan A; Ansell SM; Link BK; Zou L; Gould J; Saksena G; Stransky N; Rangel-Escareño C; Fernandez-Lopez JC; Hidalgo-Miranda A; Melendez-Zajgla J; Hernández-Lemus E; Schwarz-Cruz y Celis A; Imaz-Rosshandler I; Ojesina AI; Jung J; Pedamallu CS; Lander ES; Habermann TM; Cerhan JR; Shipp MA; Getz G; Golub TR
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3879-84. PubMed ID: 22343534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis.
    Zhang W; Huang C; Liu J; Wu L; Zhang H; Wu X; Wang L; Li W; Liu W; Liu L
    Dis Markers; 2022; 2022():6441139. PubMed ID: 35937947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma.
    Li SS; Zhai XH; Liu HL; Liu TZ; Cao TY; Chen DM; Xiao LX; Gan XQ; Cheng K; Hong WJ; Huang Y; Lian YF; Xiao J
    Exp Hematol Oncol; 2022 Oct; 11(1):71. PubMed ID: 36243813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Alterations and MYD88
    Jiang S; Qin Y; Gui L; Liu P; Jiang H; Liu B; Yang J; Yang S; He X; Zhou S; Du X; Yi Y; Lin J; Shi Y
    Target Oncol; 2020 Apr; 15(2):221-230. PubMed ID: 32239385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes.
    Mosquera Orgueira A; Ferreiro Ferro R; Díaz Arias JÁ; Aliste Santos C; Antelo Rodríguez B; Bao Pérez L; Alonso Vence N; Bendaña López Á; Abuin Blanco A; Melero Valentín P; Peleteiro Raindo AR; Cid López M; Pérez Encinas MM; González Pérez MS; Fraga Rodríguez MF; Bello López JL
    PLoS One; 2021; 16(5):e0248886. PubMed ID: 33945543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.